Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549)
2007

Ciclesonide Uptake and Metabolism in Lung Cells

Sample size: 5 publication Evidence: high

Author Information

Author(s): Nonaka Takashi, Nave RĂ¼diger, McCracken Nigel, Kawashimo Atsuko, Katsuura Yasuhiro

Primary Institution: Teijin Institute for Biomedical Research, Teijin Pharma Limited

Hypothesis

This study investigates the uptake and metabolism of ciclesonide in human alveolar type II epithelial cells (A549).

Conclusion

Ciclesonide is taken up more efficiently than fluticasone propionate in A549 cells, with stable levels of its active metabolite des-CIC maintained for up to 24 hours.

Supporting Evidence

  • Ciclesonide showed a 2.1-fold higher concentration in A549 cells compared to fluticasone propionate after 30 minutes.
  • 96% of ciclesonide remained un-metabolized after 30 minutes of incubation.
  • Des-CIC-oleate was identified as the main metabolite of ciclesonide.

Takeaway

Ciclesonide is better absorbed by lung cells than another drug called fluticasone, and it stays active in the cells for a long time.

Methodology

A549 cells were incubated with ciclesonide or fluticasone propionate, and their concentrations were measured using high performance liquid chromatography with tandem mass spectrometry.

Statistical Information

P-Value

p < 0.001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1471-2210-7-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication